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Abstract  
Background. Day Hospital Mentalization-Based Treatment (MBT-DH) is a promising 
treatment for borderline personality disorder (BPD), but its evidence base is still limited. This 
multi-site randomized trial compared the efficacy of MBT-DH delivered by a newly set-up 
service versus specialist treatment as usual (S-TAU) tailored to the individual needs of 
patients, and offered by a well-established treatment service. 
 
Methods. Two mental healthcare institutes in the Netherlands participated in the study. 
Patients who met DSM-IV criteria for BPD and had a score of ≥20 on the Borderline 
Personality Disorder Severity Index (BPDSI) were randomly allocated to MBT-DH (N=54) 
or S-TAU (N=41). The primary outcome variable was the total score on the BPDSI. 
Secondary outcome variables included symptom severity, quality of life, and interpersonal 
functioning. Data were collected at baseline and every 6 months until 18-month follow-up, 
and were analyzed using multilevel analyses based on intention-to-treat principles.  
 
Results. Both treatments were associated with significant improvements on all outcome 
variables. MBT-DH was not superior to S-TAU on any outcome variable. MBT-DH was 
associated with higher acceptability in BPD patients compared versus S-TAU, reflected in 
significantly higher early drop-out rates in S-TAU (34%) versus MBT-DH (9%).  
 
Conclusions. MBT-DH delivered by a newly set-up service is as effective as specialist TAU 
in The Netherlands in the treatment of BPD at 18-month follow-up. Further research is 
needed to investigate treatment outcomes in the longer term and the cost-effectiveness of 
these treatments.  
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Introduction  
Borderline personality disorder (BPD) is one of the most prevalent mental disorders in 
psychiatric populations (Leichsenring et al. 2011) and is associated with low quality of life 
(QoL) (Laurenssen et al. 2016), high psychiatric comorbidity (Zanarini et al. 1998), and high 
socioeconomic burden (Laurenssen et al. 2016). Treatment guidelines and meta-analyses 
(National Institute for Health and Clinical Excellence 2009; Stoffers et al. 2012) suggest that 
Day Hospital Mentalization-Based Treatment (MBT-DH) (Bateman and Fonagy 1999, 2004) 
is a promising treatment for BPD. The goal of MBT-DH is to enhance patients’ mentalizing 
capacity, particularly in high arousal contexts. The term mentalizing refers to “the mental 
process by which an individual implicitly and explicitly interprets the actions of himself and 
others as meaningful on the basis of intentional mental states such as personal desires, needs, 
feelings, beliefs, and reasons” (Bateman and Fonagy 2004, p. xxi). Studies suggest that 
impairments in mentalizing are a core feature of patients with BPD, and are related to 
problems with affect regulation and attentional control. Hence, improving mentalizing 
capacity is thought to be associated with a decreased need to rely on maladaptive coping 
strategies to deal with feelings of inner emptiness, impulsivity, and conflicts in interpersonal 
relationships, thereby decreasing symptoms and enhancing interpersonal functioning 
(Bateman and Fonagy 2004).  
Research on the effectiveness of MBT-DH is still relatively scarce. In a sample of 38 
BPD patients, Bateman and Fonagy (Bateman and Fonagy 1999) compared the effectiveness 
of MBT-DH with that of treatment as usual (TAU; standard psychiatric care). After 18 
months of treatment, MBT-DH was superior to TAU on all major outcome variables, 
including depressive symptoms, suicide attempts and self-harm, number of inpatient days, 
and social and interpersonal functioning (Bateman and Fonagy 1999). These results were 
maintained during the 18-month follow-up period (Bateman and Fonagy 2001) up to 5 years 
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after discharge (Bateman and Fonagy 2008). Two other non-randomized studies, independent 
from the developers of MBT-DH, have provided further support for MBT-DH. Bales and 
colleagues (Bales et al. 2012) investigated the effectiveness of MBT-DH in a naturalistic 
study in the Netherlands. They found significant improvements at 18 months treatment on all 
outcome variables, including a reduction in healthcare consumption. In another study, Bales 
and colleagues (Bales et al. 2012) matched 29 BPD patients receiving MBT-DH to 29 BPD 
patients receiving other evidence-based psychotherapeutic treatments (OPT) in a non-
randomized study. Patients in both MBT-DH and OPT improved on all outcome measures, 
including psychiatric symptoms and personality functioning at 36-month follow-up. 
However, at 36-month follow-up, the MBT-DH condition was superior to OPT on all 
outcome measures except for relational functioning (Bales et al. 2012).  
Existing research concerning the effectiveness of MBT-DH shows limitations beyond 
its scarcity. These include potential researcher allegiance (Bateman and Fonagy 1999), 
problems with the generalizability of results to other countries given the large differences in 
healthcare systems between countries (Bateman and Fonagy 1999), the lack of a control 
group (Bales et al. 2012), and the use of a nonrandomized design (Bales et al. 2012) in some 
studies. In addition, Bateman and Fonagy (Bateman and Fonagy 1999) compared MBT-DH 
with general psychiatric care, which does not involve formal psychotherapy. However, 
formal psychotherapy is the treatment of choice according to treatment guidelines (National 
Institute for Health and Clinical Excellence 2009; Stoffers et al. 2012). Therefore, the present 
study compared the efficacy of MBT-DH with specialist TAU (S-TAU) involving evidence-
based psychotherapy, thus comparing an evidence-based treatment program to another 
effective treatment (Committee on Comparative Effectiveness Research Prioritization 2009). 
Furthermore, recent studies suggest that implementing specialist treatments such as MBT in 
routine care may be more difficult than initially thought, as implementation problems have 
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shown to negatively influence the outcome of MBT-DH in BPD patients, with effect sizes 
being two to three times smaller compared with well-implemented MBT-DH (Bales, 
Timman, Luyten, Hutsebaut, & Verheul, 2017). 
The present study thus aimed to further investigate the efficacy of MBT-DH offered 
by a newly set up service that was trained to deliver MBT-DH, as compared with manualized 
S-TAU in BPD patients (Laurenssen et al. 2014b) that was offered by a well-established 
specialized treatment center and consisted of evidence-based interventions such as dialectical 
behavior therapy (DBT) and emotion regulation therapy, tailored to the individual needs of 
patients. The primary hypothesis was that MBT-DH and S-TAU were both associated with 
significant improvements on primary and secondary outcomes. The primary outcome in this 
study was the Borderline Personality Disorder Severity Index (BPDSI). The secondary 
hypothesis was that MBT-DH would be associated with at least 20% more improvement than 
S-TAU on the BPDSI at 18 months after the start of the intervention (Laurenssen et al. 
2014b). When this trial was initiated in 2006, TAU for these patients was still quite variable. 




This study was approved by the Medical Ethics Review Committee of the University of 
Rotterdam, the Netherlands. For a detailed description of the study protocol, see (Laurenssen 
et al. 2014b). Briefly, two mental healthcare centers, both located in Amsterdam, agreed to 
participate in this study. The City Crisis Service agreed to run the S-TAU condition (see 
below). From March 2009 to July 2012, patients were referred to one of the two mental 
healthcare centers in Amsterdam. Patients meeting inclusion criteria were provided with a 
complete description of the study, after which written informed consent to participate was 
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obtained. Patients agreeing to participate were randomly assigned to either MBT-DH or S-
TAU using block randomization taking into account the availability of treatment programs. 
For this reason, the randomization was slightly skewed in favor of MBT-DH, because the 
new MBT-DH groups needed to be filled. Randomization was done by an independent 
researcher, away from the site, using a computer algorithm. 
 
Participants 
Participants were 95 patients with a BPD diagnosis as assessed with the Structured Clinical 
Interview for DSM-IV Axis II Personality Disorders (SCID-II) (Weertman et al. 2000) and a 
total score on the BPDSI (Arntz et al. 2003) of at least 20, reflecting severe BPD. Exclusion 
criteria were the presence of schizophrenia or bipolar disorder, as determined by the 
Structured Clinical Interview for DSM-IV Axis I Personality Disorders (SCID-I) (Van 
Groenestijn et al. 1999), substance abuse requiring specialist treatment, organic brain 
disorder, IQ below 80, and inadequate mastery of the Dutch language. Figure 1 shows the 
flow of participants through the study.  
 
Assessments 
Patients completed the BPDSI, SCID-I and SCID-II before randomization. Other baseline 
assessments were completed after randomization. Follow-up interviews and assessments were 
conducted every 6 months until 36-month follow-up. Research assistants were psychologists 
with an MSc degree, and were blind for treatment condition. The primary outcome measure 
was the frequency and severity of BPD features as measured by the total score on the BPDSI 
(Arntz et al. 2003). The BPDSI is a semi-structured interview, developed to assess BPD 
features as defined by DSM-IV criteria (American Psychiatric Association 1994), and  
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Assessed for eligibility (n=107)
Randomized (n=95)
Allocated to MBT-DH(n=54)
· Received allocated 
intervention (n=49)




· Not meeting inclusion criteria (n=7)
· Declined to participate (n=3)
· Other reasons (n=2)
Discontinued intervention (n=16)
· < Month 6 (n=8)
· < Month 12 (n=7)
· < Month 18 (n=1)
Analysis
Allocated to TAU (n=41)
· Received allocated 
intervention (n=27)
· Did not receive allocated 
intervention y (n=14)
Discontinued intervention (n=12)
· < Month 6 (n=7)
· < Month 12 (n=3)







consists of the following nine subscales: (a) abandonment, (b) relationships, (c) identity, (d) 
impulsivity, (e) parasuicidal behavior, (f) affective instability, (g) emptiness, (h) anger-
control, and (i) dissociation and paranoid ideation. The BPDSI has been shown to be sensitive 
to change (Arntz et al. 2003). In a study of BPD patients, patients with other personality 
disorders, and patients with only Axis I disorders, the BPDSI was highly reliable (intraclass 
correlation coefficient [ICC]=.93) and internally consistent (Cronbach’s α=.85).  
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Secondary outcome measures were suicide and self-harm, assessed with the Suicide 
and Self-Harm Inventory (SSHI) (Bateman and Fonagy 2004), general psychopathological 
symptoms was measured with the Global Severity Index (GSI), which is part of the Brief 
Symptom Inventory (BSI) (De Beurs 2006), severity of depression was assessed by the Beck 
Depression Inventory (BDI-I) (Beck et al. 1961), interpersonal problems was measured with 
the Inventory of Interpersonal Problems (IIP-64) (Horowitz et al. 2000), BPD characteristics 
were assessed by the Dutch version of the Personality Assessment Inventory-Borderline 
(PAI-BOR) (Distel et al. 2009) and QoL was measured using the EuroQol EQ-5D-3L 
(Busschbach et al. 1999). Preliminary screening of the data showed substantial differences in 
the administration of the SSHI between research assistants, and therefore we decided not to 
report data using this measure.  
 
Treatment conditions 
MBT-DH. MBT-DH consists of a highly structured day hospitalization program with a 
maximum duration of 18 months, covering 5 days per week, approximately 6 hours per day. 
The treatment consists of the following components: daily group psychotherapy, weekly 
individual psychotherapy, individual crisis planning, art therapy twice a week, mentalizing 
cognitive group therapy, and writing therapy. Each week’s program ends with a social hour 
and a community meeting. Patients can also consult a psychiatrist upon request and 
medication is prescribed following American Psychiatric Association guidelines (American 
Psychiatric Association 2000). MBT-DH has been described in more detail elsewhere 
(Bateman and Fonagy 2004). 
As noted, therapists offering MBT-DH were specifically trained for this study. Team 
members were certified and registered psychologists, psychotherapists, a psychiatrist, 
sociotherapists, and a creative therapist, who volunteered to be trained in MBT-DH, and 
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followed a two-day MBT training program led by a certified MBT trainer. Although 
therapists trained in MBT were not already familiar with MBT, they were highly experienced 
in delivering treatment to patients with BPD. In addition, a certified MBT psychotherapist, a 
sociotherapist, and creative therapist supervised the team for the first week. Adherence to 
MBT was monitored in several ways: by daily group reflections after group therapy, 
fortnightly team supervisions, 2-monthly individual supervision for the team leader and 
psychotherapist, and 2-monthly group supervision for the sociotherapists and creative 
therapist. Supervisions were based on principles outlined in the MBT quality manual that was 
being developed at the time of the study (Karterud et al. 2013). The mean number of days in 
MBT-DH was 176 (range 5-402), median=149). The mean number of hours in MBT-DH was 
1056 (range 30-2412, median = 894). 
 
S-TAU. The S-TAU was offered by a well-established treatment service that has been 
involved in the treatment of BPD patients since the 1980s. The treatment consists of a 
manualized, integrative approach in which both psychiatric treatment and a systemic therapy 
approach play a central role (for a detailed description, see Van Oenen et al. 2007)). Its main 
aim is to deliver optimal care based on an extensive psychiatric examination by offering 
“system-oriented tailored care”, meaning that the optimal combination and intensity of 
interventions for each client is determined during an extensive assessment phase, which also 
focused on offering emotional and practical support and structure. Patients were subsequently 
referred to evidence-based treatments that have no explicit focus on fostering mentalizing, 
such as emotion regulation therapy, DBT, outpatient treatment for eating disorders, individual 
cognitive therapy, aggression regulation group treatment and/or inpatient treatment, 
depending on the needs of the patient. Inpatient treatment is offered in a hospital ward and 
involves individual and group therapy. Patients may also be referred to other centers for 
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treatment targeting specific problem areas (e.g., drug addiction). Similarly, outreaching 
interventions are often used to facilitate change in the patient’s environment. If patients 
preferred to be treated nearer to the area where they lived, they were referred to a specialist 
treatment provider nearer to their homes. The core team offering S-TAU consisted of five 
psychiatrists, two psychologists, five mental health nurses, and one systemic therapist, with 
between 5 and 10 years’ experience in offering this treatment. Team members were able to 
consult a psychiatrist on a daily basis. No systematic assessment of adherence was available 
because of the wide variety of treatments offered. The mean number of hours in S-TAU was 




All analyses were carried out using Stata Statistical Software Release 12 (StataCorp 2011) 
and R (Amelia-2 for R version 3.2.1+) (Honaker et al. 2011). The primary data analysis was 
done based on intention-to-treat principles. The XTMIXED procedure was used to analyze 
treatment differences and changes over time. The four time points were coded as -3, -2, -1, 
and 0 in all models for which 6-monthly data were available, thereby implying that regression 
coefficients involving time measured the rate of change from baseline to 18-month follow-up 
and that regression intercepts referenced group differences at the last follow-up point. As 
non-linear change effects over time were found in preliminary analyses, a quadratic time 
variable was added to all models to accommodate the non-linear change over time. In case 
the quadratic model was significant as well, a cubic time variable was added to the model. 
However, quadratic and cubic time variables were removed if the likelihood ratio test showed 
non-significant improvement in fit. Model parameters presented in this paper are (a) the 
overall significance of the model (Wald 2 statistic); (b) the rate of change from baseline to 
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18 months for both groups combined; (c) the differential rate of change for the MBT-DH 
group, compared with the S-TAU group; and (d) group differences at 6-, 12-, and 18-month 
follow-up. Effect sizes were calculated in terms of Cohen’s d. Differences at baseline were 
explored using univariate statistics. Sample size was determined based on a power analysis. 
With 54 patients per group, an effect size of at least .65 on the BPDSI could be detected with 
a power of 92% (α=.05, β=.083), which reflects a reasonable, realistic, and clinically relevant 
effect (Laurenssen et al. 2014b). Because of the randomization procedure, 54 patients were 
referred to MBT-DH and 41 patients to S-TAU, resulting in a power of 88.2%. 
As in most treatment studies with BPD patients, missing data was considerable in this 
study (approximately 45% across both conditions and all measurement times); we therefore 
decided to rerun all analyses on an imputed dataset. The multiple imputation software 
Amelia-2 (for R version 3.2.1+) was used to deal with missing data (Honaker et al. 2011). 
Simulation studies have indicated that this software package can yield valid estimates of 
missingness at random in longitudinal data, even if outcome data are skewed or dichotomous 
(Blankers et al. 2010). Five instances of missing data in the original dataset were imputed. In 
order to impute with non-linear trends over time, time was added as a second-degree 
polynomial variable. After the imputation process, analyses were performed on each of the 
five datasets separately. In a final step, results from these five analyses were combined using 
Rubin’s rules for combining estimates obtained from multiple imputed datasets (Rubin 1987). 
Estimated trajectories of change and effect sizes were highly similar based on the imputed 
and non-imputed data. In this paper, we therefore report only results based on the non-
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Descriptive features and dropout 
The treatment groups did not significantly differ from each other on any of the baseline 
variables (see Table 1). Five patients (9%) in the MBT-DH group versus 14 patients (34%) in 
the S-TAU group never started treatment or refused to participate in the study after 
randomization; this difference between both groups was significant: 2(1)=9.02, p=.003. Of 
the patients who started treatment, 39% (n=16) in the MBT-DH group and 44% (n=12) the S-
TAU group dropped out; this difference was not significant: 2(1)=1.04, p=.31. No serious 
adverse events occurred during the trial. 
 
Primary outcome 
A cubic random intercepts and slopes model best fitted the change in the BPDSI (see Table 2 
and Figure 2). Both groups showed significant reductions on the BPDSI. The within-group 
effect sizes were large for both MBT-DH (d=1.33) and S-TAU (d=1.28). However, MT-DH 
and S-TAU showed a very different pattern of change over time. MBT-DH followed a linear 
pattern from baseline to 18-month follow-up, whereas S-TAU initially showed a steeper 
decrease in BPDSI scores; this was also apparent from the finding that at 6-month follow-up, 
scores on the BDPSI were significantly lower in S-TAU than in MBT. However, this steeper 
linear decrease for S-TAU was modified by a cubic and quadratic trend after 6 months, and at 
12- and 18-month follow-up, there were no longer any differences between the two groups.  
 
Table 1. Baseline Demographic and Clinical Characteristics  
Characteristic MBT-DH (N=54) S-TAU (N=41) 
 Mean SD Mean SD 
Age (years) 34.00  9.38 34.00 10.62 
BPDSI total score 34.32  8.35 32.84  7.15 
GSI score 2.09 0.78 2.13 0.68 
EQ-5D score 0.42  0.33 0.39  0.27 
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IIP-64 total score 3.16 0.38 3.10 0.38 
Number of Axis I disorders 2.33  1.59 2.34 1.61 
Number of comorbid Axis II PDs 0.70 0.90 0.54 0.67 
 N % N % 
Gender     
     Female 42 78 33 81 
Marital status     
     Married 3 6 1 2 
     Divorced 4 7 5 12 
     Partner relationship 5 9 2 5 
     Living together 4 7 5 12 
     Single 38 70 25 61 
Vocational status      
     Employed 13 24 5 12 
     Unemployed 27 50 27 66 
     Student 2 4 1 2 
     Unknown 12 22 8 20 
Most common Axis I disorders     
     Mood disorder 34 63 28 68 
     Substance use disorder 24 45 22 54 
     Anxiety disorder 23  43 16 39 
     Eating disorder 12 11 8 20 
Most common comorbid Axis II PDs     
     Avoidant PD 15 28 7 17 
     Antisocial PD 8  7 5  6 
     Paranoid PD 6 5 3 4 
     Obsessive-compulsive PD 5  5 3  4 
     Dependent PD 3 2 1 2 
Note. MBT-DH = Day Hospital Mentalization-Based Treatment, S-TAU = Specialist 
treatment as usual, SD = standard deviation, BPDSI = Borderline Personality Disorder 
Severity Index, GSI = Global Severity Index, IIP-64 = Inventory of Interpersonal Problems, 






Table 2. Results from Mixed-Effects Random Regression Models for the Primary 
Outcome, BPDSI. 
 BPDSI 
 Intention to treat 
 MBT-DH (N=54) S-TAU (N=41) 
 Mean SD Mean SD 
Baseline 34.32  8.35 32.84 7.15 
6 months 30.64  12.34 24.53 10.59 
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12 months 25.60  12.94 25.49 10.56 





Model: Wald ² (df=7) 88.70**  
Linear change (both groups) -10.82* -21.43, -0.22 
Differential linear change (MBT-DH) 9.71 -3.10, 22.52 
Quadratic change (both groups) -8.75* -17.33, -0.16 
Differential quadratic change (MBT-DH) 11.03* 0.51, 21.55 
Cubic change (both groups) -2.22* -4.04, -0.41 
Differential cubic change (MBT-DH) 2.66* 0.43, 4.90 
Group differences at 18 months 3.43 -3.72, 10.57 
Constant 18.97 13.14, 24.80 
Note. MBT-DH = Day Hospital Mentalization-Based Treatment, S-TAU = Specialist 
treatment as usual, SD = standard deviation, BPDSI = Borderline Personality Disorder 
Severity Index, CI = Confidence Interval.  






Figure 2. Scores on the BPDSI for both groups over time.  
 
Secondary outcomes 
A linear random intercepts and slopes model best fitted the trajectories of change in the BDI, 
GSI, EQ-5D, PAI-BOR, and IIP-64. Both MBT-DH and S-TAU showed a significant 
improvement on all secondary outcome measures at 18-month follow-up. There were no 
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significant differences between the two groups on any of the secondary outcome measures at 
18-month follow-up, nor was evidence found for differential rates of change between 
conditions. All within-group pretreatment–posttreatment effect sizes were moderate to large, 
with the exception of changes in the EQ-5D, which were small to moderate in MBT-DH 
(Table 3; see data supplement).  
 
Discussion 
The non-superiority of MBT-DH over S-TAU as found in this study is consistent with 
increasing evidence that well-specified treatments for BPD that are delivered in a consistent, 
coherent, and continuous way tend to be equally effective, irrespective of their theoretical 
orientation. This has been shown in recent trials comparing outpatient MBT (Bateman and 
Fonagy 2009), DBT (McMain et al. 2012), transference-focused psychotherapy (Clarkin et 
al. 2007), and cognitive analytic therapy (Chanen et al. 2008), with other treatments that meet 
the criteria of consistent, coherent, and continuous treatment delivery. Several studies have 
suggested that impairments in mentalizing are a core feature of patients with BPD, and are 
related to problems with affect regulation and attentional control. One of the main key 
ingredients of MBT is its focus on improving patients’ mentalizing. This explicit focus on 
mentalizing was not a core component of treatments in the S-TAU condition. Yet, as 
mentalizing has been proposed to be a common mechanism of change in all effective 
treatments for BPD (Cristea et al. 2017; Fonagy et al. 2017a, b; Fonagy et al. 2017c), it 
cannot be excluded that mentalizing were related to changes in both conditions. This will be 
the focus of a separate paper. 
A major finding of this study, in this context, was the significantly higher dropout 
immediately after randomization in the S-TAU condition (34%) than in MBT-DH (9%). This 
could be the result of differences in the way that patients perceived the two interventions. 
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Patients allocated to S-TAU were told that they would receive treatment that was specifically 
tailored to their needs, meaning that the frequency, duration, and even treatment location was 
not clear from the outset. In MBT-DH, by contrast, a clear treatment plan, including the 
frequency and length of treatment, was presented from the start of the treatment. This may 
have had a greater appeal for the participants; because of BPD patients’ need for consistency 
and coherence (Fonagy et al. 2015).  
Taken together, these findings stress the need for further research on the role of 
treatment-specific factors and techniques versus whether these treatment-specific techniques 
are delivered in a consistent, coherent, and continuous way (Fonagy et al. 2015). Consistent 
with the latter assumption, a number of integrative treatment approaches for BPD have 
recently been proposed that primarily focus on common effective principles and coherence of 
the treatment approach (Livesley 2012; Bateman and Krawitz 2013).  
Given that MBT-DH was provided by a newly set-up service, implementation issues 
may have mitigated the treatment effects of MBT-DH. Although therapists trained in 
MBT were highly experienced clinicians, they had almost no prior experience with MBT. 
Therapists were, however, trained and supervised by a certified MBT trainer, and 
their adherence to the MBT model was rated as acceptable. However, we cannot exclude the 
possibility that this lack of experience with MBT may have had an impact on the outcome of 
MBT-DH when compared to S-TAU, particularly as the S-TAU was well-established and 
administered by professionals with years of experience with their approach. In addition, one 
of the sites (Arkin) that offered MBT-DH went through an intensive internal reorganisation 
during the trial, which led to uncertainty whether MBT-DH could continue to be offered. A 
recent study in this context showed that effect sizes of MBT offered in a service undergoing 
reorganization may be half or even only a third of those observed in well-implemented MBT 
(Bales et al. 2017). Although secondary analyses yielded no significant differences in 
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outcome between the two MBT-DH sites in this trial, this analysis was underpowered for 
such a comparison, and therefore we cannot rule out the possibility that the outcome of MBT-
DH, when compared to S-TAU, was mitigated because of these organization issues. In the 
current study, although the effect size obtained on the primary outcome measure was 
comparable to those reported in earlier research on MBT-DH (Bateman and Fonagy 1999; 
Bales et al. 2012), effect sizes on several secondary outcomes were substantially lower than 
in other trials of MBT-DH (Bateman and Fonagy 1999; Bales et al. 2012; Bales et al. 2015), 
which may indeed point to implementation and adherence problems in the MBT condition. 
This was particularly the case for interpersonal functioning and quality of life. Although this 
may reflect a chance finding, one additional possible explanation is that because MBT-DH 
involves patients attending treatment on 5 days a week, it may limit these patients’ ability to 
experiment with new ways of thinking, feeling, and behaving in the outside world. This 
interpretation is consistent with the recent emphasis on step-down programs in the treatment 
of BPD and the focus on fostering recovery of the capacity for social learning and 
salutogenesis (the capacity to benefit from positive features in the environment) in these 
patients (Fonagy et al. 2015). Future research is needed to investigate these assumptions. 
Results from an on-going trial comparing MBT-DH with an intensive outpatient MBT 
treatment (MBT-IOP), promise to shed more light on the effects of hospitalization in MBT 
(Laurenssen et al. 2014a). With regard to identifying future training needs and the cost-
effective provision of services for BPD patients, it should be noted that MBT was associated 
with equivalent outcomes with therapists receiving only 2 days of training and subsequent 
supervision, compared with a well-organized service with considerable experience in treating 
these patients. 
A major strength of the study is that it is the first independent study to compare MBT-
DH with a well-established specialist TAU. However, the study also has several limitations. 
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First, the randomization was slightly skewed in favor of MBT-DH, because the new MBT-
DH groups needed to be filled. Nevertheless, there were no baseline differences between 
patients in MBT-DH and S-TAU. Second, the baseline assessment for secondary outcome 
measures was performed after randomization. The outcome of the randomization may 
therefore have had some effects on this baseline assessment. Third, there was no quantitative 
assessment of treatment adherence. Although the team was supervised by a certified MBT 
therapist following principles outlined in a quality manual in order to obtain adherence to the 
MBT protocol (Bateman et al. 2012), there was no formal assessment of treatment adherence. 
Given that adherence to the MBT model has been positively associated with treatment 
outcome (Bales et al. 2017), this is an important limitation of this study. In combination with 
the implementation problems of MBT in the current study, if anything, this study may have 
underestimated the effects of MBT. Fourth, dropout during treatment was relatively high, 
although comparable with other studies in the field (Giesen-Bloo et al. 2006; Blum et al. 
2008). To address this issue, we conducted post-hoc analyses comparing effect sizes based on 
imputed and non-imputed data, and on both the intention-to-treat and completer samples. 
Results were highly comparable. Fifth, the effects of both treatments may differ at longer 
follow-ups. This will be the focus of a future report. In this context, issues concerning cost-
effectiveness may also be important. Sixth, in hindsight, given that meta-analyses carried out 
since this study was designed have shown that there are very few, if any, differences in the 
effectiveness of well-organized treatments such as those investigated in this paper (Cristea et 
al. 2017), the current study may have been underpowered to detect meaningful differences 
between the two treatments investigated in this study. Yet, as the same time, it may be 
questionable whether such small differences would be clinically meaningful. Seventh, the 
TAU comparison in this study is likely not to be representative of TAU for patients with BPD 
in many countries, where the quality of TAU for BPD patients may be much more variable. 
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On the one hand, this limits the generalizability of the results of this study. On the other hand, 
this further emphasizes the need to implement well-organized treatments for these patients, 
such as MBT and the S-TAU treatment used in this study. Finally, future studies should 
address similarities and potential differences in the mechanisms of change of both treatments.  
In conclusion, the current study suggests that MBT-DH is equally effective compared 
to a well-specified S-TAU in the treatment of BPD at 18-month follow-up. In addition, 
although presenting BPD patients with the option that their treatment will be tailored to their 
specific needs may be appealing, the lack of a clear treatment plan including frequency and 
length may have a negative impact on the engagement and motivation of patients with BPD. 
Yet, at the same time, the implementation of MBT-DH in a new setting may be challenging, 
as it may threaten the coherence and consistency of the treatment approach, which may in 
turn also mitigate treatment effects. Indeed, a recent study showed that effect sizes associated 
with MBT delivered during an organizational reorganization were only one-third of those 
observed under more optimal organizational conditions (Bales et al. 2017). In this respect, 
this study may have underestimated the effectiveness of MBT. More positively formulated, 
however, this study suggests that MBT, as delivered by therapists who are new to the model 
and who receive a 2-day training and regular supervision, is associated with effects similar to 
a well-established treatment service offering other evidence-based interventions for BPD 
patients. This finding may have important implications in terms of cost-effectiveness of 
training and service delivery in this area. Further research into these issues is needed, as well 
as studies of the cost-effectiveness and longer term outcome of both treatments. This will be 
the focus of a future report. 
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